Brain TAU isoform mrna and protein correlation in PSP brain

Translational Neuroscience

Volumn 1, Issue 1, 2010, Pages 30-36

  Luk, Connie ^a   Vandrovcova, Jana ^a   Malzer, Elke ^a   Lees, Andrew ^a   De Silva, Rohan ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; Gene expression; MAPT; MRNA; Parkinsonism; Progressive supranuclear palsy; Tau; Tauopathy

Indexed keywords

BRAIN PROTEIN; ISOPROTEIN; MESSENGER RNA; TAU PROTEIN;

AGED; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 79952356694     PISSN: 20813856     EISSN: 20816936     Source Type: Journal    
DOI: 10.2478/v10134-010-0009-8     Document Type: Article

References (37)

1. Steele, J.C., Richardson, J.C., Olszewski, J., Progressive Supranuclear Palsy. a Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum with Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia, Arch. Neurol., 1964, 10, 333-359.
2. Daniel, S.E., de Bruin, V.M., Lees, A.J., The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): A reappraisal, Brain, 1995, 118 ( Pt 3), 759-770.
3. Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R.C., et al., Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop, Neurology, 1996, 47, 1-9. (Pubitemid 26243849)
4. Maher, E.R., Lees, A.J., The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy), Neurology, 1986, 36, 1005-1008. (Pubitemid 16098253)
5. Pollock, N.J., Mirra, S.S., Binder, L.I., Hansen, L.A., Wood, J.G., Filamentous aggregates in Pick's disease, progressive supranuclear palsy, and Alzheimer's disease share antigenic determinants with microtubule-associated protein, tau, Lancet, 1986, 2, 1211. (Pubitemid 17179052)
6. Hernandez, F., Avila, J., Tauopathies, Cell Mol. Life Sci., 2007, 64, 2219-2233. (Pubitemid 47347961)
7. Ludolph, A.C., Kassubek, J., Landwehrmeyer, B.G., Mandelkow, E., Mandelkow, E.M., Burn, D.J., et al., Tauopathies with parkinsonism: Clinical spectrum, neuropathologic basis, biological markers, and treatment options, Eur. J. Neurol., 2009, 16, 297-309.
8. Williams, D.R., Tauopathies: Classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau, Intern. Med. J., 2006, 36, 652-660. (Pubitemid 44337509)
9. Goedert, M., Spillantini, M.G., Jakes, R., Rutherford, D., Crowther, R.A., Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease, Neuron, 1989, 3, 519-526.
10. Buee, L., Delacourte, A., Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease, Brain Pathol., 1999, 9, 681-693. (Pubitemid 29470961)
11. de Silva, R., Lashley, T., Gibb, G., Hanger, D., Hope, A., Reid, A., et al., Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies, Neuropathol. Appl. Neurobiol., 2003, 29, 288-302. (Pubitemid 36718177)
12. Togo, T., Sahara, N., Yen, S.H., Cookson, N., Ishizawa, T., Hutton, M., et al., Argyrophilic grain disease is a sporadic 4-repeat tauopathy, J. Neuropathol. Exp. Neurol., 2002, 61, 547-556. (Pubitemid 34603003)
13. Delacourte, A., Sergeant, N., Wattez, A., Gauvreau, D., Robitaille, Y., Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation, Ann. Neurol., 1998, 43, 193-204. (Pubitemid 28110121)
14. Sergeant, N., David, J.P., Lefranc, D., Vermersch, P., Wattez, A., Delacourte, A., Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases, FEBS Lett., 1997, 412, 578-582. (Pubitemid 27337113)
15. Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., et al., Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17, Nature, 1998, 393, 702-705.
16. Spillantini, M.G., Murrell, J.R., Goedert, M., Farlow, M.R., Klug, A., Ghetti, B., Mutation in the tau gene in familial multiple system tauopathy with presenile dementia, Proc. Natl. Acad. Sci. U S A, 1998, 95, 7737-7741. (Pubitemid 28293323)
17. Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez- Tur, J., et al., Association of an extended haplotype in the tau gene with progressive supranuclear palsy, Hum. Mol. Genet., 1999, 8, 711-715. (Pubitemid 29139987)
18. Houlden, H., Baker, M., Morris, H.R., MacDonald, N., Pickering-Brown, S., Adamson, J., et al., Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype, Neurology, 2001, 56, 1702-1706. (Pubitemid 32574570)
19. Pittman, A.M., Myers, A.J., Abou-Sleiman, P., Fung, H.C., Kaleem, M., Marlowe, L., et al., Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration, J. Med. Genet., 2005, 42, 837-846. (Pubitemid 41598191)
20. Myers, A.J., Kaleem, M., Marlowe, L., Pittman, A.M., Lees, A.J., Fung, H.C., et al., The H1c haplotype at the MAPT locus is associated with Alzheimer's disease, Hum. Mol. Genet., 2005, 14, 2399-2404. (Pubitemid 41418001)
21. Chambers, C.B., Lee, J.M., Troncoso, J.C., Reich, S., Muma, N.A., Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease, Ann. Neurol., 1999, 46, 325-332. (Pubitemid 29416270)
22. Takanashi, M., Mori, H., Arima, K., Mizuno, Y., Hattori, N., Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration, Brain Res. Mol. Brain Res., 2002, 104, 210-219.
23. Spillantini, M.G., Bird, T.D., Ghetti, B., Frontotemporal dementia and Parkinsonism linked to chromosome 17: A new group of tauopathies, Brain Pathol., 1998, 8, 387-402. (Pubitemid 28186074)
24. Luk, C., Giovannoni, G., Williams, D.R., Lees, A.J., de Silva, R., Development of a sensitive ELISA for quantification of three- and four-repeat tau isoforms in tauopathies, J. Neurosci. Meth., 2009, 180, 34-42.
25. Hanger, D.P., Betts, J.C., Loviny, T.L., Blackstock, W.P., Anderton, B.H., New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry, J. Neurochem., 1998, 71, 2465-2476. (Pubitemid 28531257)
26. Tobin, J.E., Latourelle, J.C., Lew, M.F., Klein, C., Suchowersky, O., Shill, H.A., et al., Haplotypes and gene expression implicate the MAPT region for Parkinson disease: The GenePD Study, Neurology, 2008, 71, 28-34.
27. Williams, D.R., Holton, J.L., Strand, C., Pittman, A., de Silva, R., Lees, A.J., et al., Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome, Brain, 2007, 130, 1566-1576. (Pubitemid 47355935)
28. Dickson, D.W., Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration, J. Neurol., 1999, 246 Suppl 2, I6-I15.
29. Wakabayashi, K., Takahashi, H., Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration, Neuropathology, 2004, 24, 79-86. (Pubitemid 38391499)
30. Ezquerra, M., Gaig, C., Ascaso, C., Munoz, E., Tolosa, E., Tau and saitohin gene expression pattern in progressive supranuclear palsy, Brain Res., 2007, 1145, 168-176. (Pubitemid 46509623)
31. Motoi, Y., Takanashi, M., Itaya, M., Ikeda, K., Mizuno, Y., Mori, H., Glial localization of four-repeat tau in atypical progressive supranuclear palsy, Neuropathology, 2004, 24, 60-65. (Pubitemid 38391496)
32. Mott, R.T., Dickson, D.W., Trojanowski, J.Q., Zhukareva, V., Lee, V.M., Forman, M., et al., Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias, J. Neuropathol. Exp. Neurol., 2005, 64, 420-428. (Pubitemid 40629133)
33. Lichtinghagen, R., Musholt, P.B., Lein, M., Romer, A., Rudolph, B., Kristiansen, G., et al., Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue, Eur. Urol., 2002, 42, 398-406. (Pubitemid 35175803)
34. Gygi, S.P., Rochon, Y., Franza, B.R., Aebersold, R., Correlation between protein and mRNA abundance in yeast, Mol. Cell. Biol., 1999, 19, 1720-1730. (Pubitemid 29098230)
35. Chen-Plotkin, A.S., Xiao, G., Geser, F., Martinez-Lage, M., Grossman, M., Unger, T., Wood, E.M., Van Deerlin, V.M., Trojanowski, J.Q., Lee, V.M-Y., Brain progranulin expression in GRN-associated frontotemporal lobar degeneration, Acta Neuropathol., 2010, 119, 111-122.
36. Nelson, P.T., Keller, J.N., RNA in brain disease: No longer just "the messenger in the middle", J. Neuropathol. Exp. Neurol., 2007, 66, 461-468. (Pubitemid 46869688)
37. Kingsbury, A.E., Foster, O.J., Nisbet, A.P., Cairns, N., Bray, L., Eve, D.J., et al., Tissue pH as an indicator of mRNA preservation in human postmortem brain, Brain Res. Mol. Brain Res., 1995, 28, 311-318.